Although it has not been proven whether the compound directly binds to UGT8 to inhibit its enzymatic activity, compound 19 has been shown to decrease the amount of GalCer in the adenocarcinoma cell line OE19 and the mouse brain and kidney (7,19). This evidence concerns the gene UGT8 and adenocarcinoma.